News and media

The Therapeutic Goods Administration (TGA) has provisionally approved the Oxford/AstraZeneca COVID-19 vaccine for use in Australia.

More than 142,000 doses of the Pfizer/BioNTech COVID-19 vaccine have arrived at Sydney airport in a major milestone in Australia’s response to the pandemic. Read more about how the vaccines will be rolled out.

You can provide comments through public webinars that will be held between 16 February 2021 and 30 March 2021.

The Australian Government Chief Medical Officer has declared the Greater Melbourne area a COVID-19 hotspot for the purposes of Commonwealth support.

The Australian Government is providing $7 million through the Medical Research Future Fund for research into neurofibromatosis.

Clinicians, academics and consumers are invited to express their interest in participating in the MBS ECG Review Committee, which will review changes to MBS ECG items introduced on 1 August 2020 following implementation of recommendations from the MBS Review Taskforce.

New information about the COVID-19 vaccine rollout to residential aged care facilities is now available.

Read the Prime Minister’s update following the National Cabinet meeting on 5 February 2021.

We invite you to share your views on the proposed approach to making mitochondrial donation available in Australia. The government wants to introduce mitochondrial donation so this lifesaving technology is made available in Australia for some families impacted by severe mitochondrial disease.

Australia has secured an extra 10 million doses of the Pzifer/BioNTech COVID-19 vaccine, bringing the total number of doses of this vaccine to 20 million.

An updated statement from the Australian Health Protection Principal Committee (AHPPC) on on minimising the potential risk of COVID-19 transmission in schools.

The Prime Minister has outlined plans to deliver Australia's COVID-19 vaccination program this year. Find out more.